HCT Fellowship Faculty

Monzr M. Al Malki, M.D., is an associate professor in the Department of Hematology & Hematopoietic Cell Transplantation and is board certified in internal medicine, hematology and medical oncology at City of Hope.

Andrew Artz, M.D., M.S., is a professor at City of Hope’s Hematologic Malignancies Research Institute.

John Baird, M.D., is a hematologist-oncologist and assistant professor, Division of Lymphoma, Department of Hematology & Hematopoietic Cell Transplantation at City of Hope.

Elizabeth Budde, M.D., Ph.D., is an oncologist and associate professor at City of Hope.

Alex Herrera, M.D., is chief of the Division of Lymphoma and a hematologist-oncologist at City of Hope specializing in treating and researching lymphoma.

Maung Myo Htut, M.D., is determined to find more effective treatments for multiple myeloma, a rare blood cancer that strikes about 30,000 Americans each year. He believes the body's own immune system may hold the key.

Murali Janakiram, M.D., M.S., is a hematologist-oncologist and associate professor in the Department of Hematology & Hematopoietic Cell Transplantation.

Matthew Genyeh Mei, M.D., Hematologic Malignancies and Stem Cell Transplantation Institute | City of Hope in Southern California.

Ryotaro Nakamura, M.D., is the Jan & Mace Siegel Professor in Hematology & Hematopoietic Cell Transplantation professor and a hematologist/oncologist at City of Hope.

Vinod Pullarkat, M.D., is a hematologist/oncologist in the Department of Hematology & Hematopoietic Cell Transplantation.

Karamjeet Sandhu, M.D., is a hematologist oncologist at City of Hope Cancer Center near Los Angeles, CA.

F. Marc Stewart, M.D., is a hematologist-oncologist and serves as chief clinical officer for City of Hope Duarte and the Los Angeles-area clinical network sites.